 "Wockhardt declines ahead of Q4 results")
Shares of Wockhardt have dipped 9% to Rs 1,429 on the NSE in intra-day trades ahead of the January-March (Q4) quarter earnings today.
“The meeting of board of directors of the company will be held on May 28, 2015, to consider the annual audited consolidated and standalone financial statements of the company for the year ended March 31, 2015,” Wockhardt said in a statement.
For the nine months ended December 2014, the company had reported consolidated net profit of Rs 371 crore against Rs 766 crore in the same period last year.
Meanwhile, the drug maker said that US Food and Drug Administration (FDA) completed its inspection at its plants in Waluj and Chikalthana in Maharashtra.
"This is to inform you the exchange that inspection of our manufacturing unit at H14/2 Waluj, Aurangabad, Maharashtra by US FDA has since been completed,” the company said in a regulatory filing on clarification on news report.
In the past two weeks, the stock has appreciated by 24% compared to a 2.6% rise in the CNX Nifty till Wednesday.
At 1331 hours, the stock was down 7% at Rs 1,464 and a combined 3.55 million shares changed hands on the counter on the NSE and BSE.
“The meeting of board of directors of the company will be held on May 28, 2015, to consider the annual audited consolidated and standalone financial statements of the company for the year ended March 31, 2015,” Wockhardt said in a statement.
For the nine months ended December 2014, the company had reported consolidated net profit of Rs 371 crore against Rs 766 crore in the same period last year.
Meanwhile, the drug maker said that US Food and Drug Administration (FDA) completed its inspection at its plants in Waluj and Chikalthana in Maharashtra.
"This is to inform you the exchange that inspection of our manufacturing unit at H14/2 Waluj, Aurangabad, Maharashtra by US FDA has since been completed,” the company said in a regulatory filing on clarification on news report.
In the past two weeks, the stock has appreciated by 24% compared to a 2.6% rise in the CNX Nifty till Wednesday.
At 1331 hours, the stock was down 7% at Rs 1,464 and a combined 3.55 million shares changed hands on the counter on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%